Abstract
Patients with malignancy, who are unable to meet their nutritional needs through oral or enteral routes, and who have at least a 3-months prognosis and good performance status, should be considered for Home Parenteral Nutrition (HPN)1. The number of patients with cancer receiving HPN in the UK is rising. Given the increase in utilisation, it is important to evaluate response to treatment and ensure robust decision making is in place. This audit aimed to review the outcomes of patients commenced on palliative HPN for this indication in our centre.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
